Clinical Observation of the Performance of Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line in Treatments of Patients With End-Stage Renal Disease (ESRD)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 276 participants.

Also called NCT03859830

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 276 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03859830
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03859830. Randomized; no masking; primary purpose treatment. Start 2019-01-22 (actual); primary completion 2019-11-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Observation of the Performance of Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line in Treatments of Patients With End-Stage Renal Disease (ESRD)
Condition
End-Stage Renal Disease
Intervention (Device)
Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line
Intervention (Device)
AK200 Ultra S, extracorporeal circulation conduct of blood purification
Lead sponsor
Vantive Health LLC (class: industry)
Collaborator
Baxter Healthcare Corporation (class: industry)

Record details

Record id
cardio:ct-nct03859830
Content hash
a38f9cf285f527c88b5c193d40bc484d35bb640bc2329d58ca11f0bed742b091